| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,244 |
4,020 |
$133K |
| 85027 |
|
18,538 |
14,296 |
$14K |
| 80053 |
Comprehensive metabolic panel |
8,247 |
6,940 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,823 |
7,280 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
355 |
353 |
$4K |
| 88342 |
|
150 |
144 |
$3K |
| 84484 |
|
2,627 |
2,489 |
$2K |
| 83690 |
|
3,598 |
3,478 |
$2K |
| 83735 |
|
2,155 |
1,523 |
$1K |
| 88304 |
|
167 |
161 |
$1K |
| 80076 |
|
1,639 |
1,561 |
$855.59 |
| 82248 |
|
2,927 |
2,795 |
$754.01 |
| 82553 |
|
393 |
357 |
$456.74 |
| 81001 |
|
2,473 |
2,428 |
$432.20 |
| 82550 |
|
597 |
532 |
$399.06 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
606 |
598 |
$396.70 |
| 85007 |
|
1,684 |
1,373 |
$371.53 |
| 81003 |
|
1,911 |
1,855 |
$365.21 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16 |
16 |
$299.25 |
| 84703 |
|
851 |
836 |
$285.27 |
| 85610 |
|
653 |
518 |
$217.62 |
| 87040 |
|
153 |
146 |
$188.20 |
| 84100 |
|
332 |
228 |
$149.11 |
| 83605 |
|
138 |
131 |
$146.49 |
| 80305 |
|
43 |
43 |
$80.19 |
| 85730 |
|
70 |
50 |
$67.07 |
| 84443 |
Thyroid stimulating hormone (TSH) |
24 |
24 |
$17.67 |
| 86901 |
|
69 |
62 |
$17.01 |
| 86900 |
|
68 |
61 |
$16.08 |
| 87186 |
|
12 |
12 |
$14.03 |
| 86850 |
|
42 |
36 |
$13.26 |
| 87077 |
|
12 |
12 |
$10.52 |
| 87081 |
|
12 |
12 |
$7.02 |
| 83880 |
|
13 |
13 |
$5.97 |
| 86140 |
|
18 |
15 |
$5.89 |
| 81025 |
|
30 |
30 |
$5.60 |
| 84702 |
|
12 |
12 |
$5.30 |
| 87420 |
|
22 |
22 |
$1.15 |